The purpose of this study is to determine the efficacy of combination therapy with etiocholanolone, androgens and cyclosporin-A in patients with aplastic anemia. In the last 12 months we have seen three patients with aplastic anemia. Two patients entered a partial remission with artithymocyte globulin and cyclosporine therapy. One patient received a matched, sibling marrow transplant at the M.D. Anderson Cancer Center in Houston. She is doing very well post transplant. Thus, no patient with aplastic anemia became available to enter this study.
Showing the most recent 10 out of 396 publications